Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

135 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.
Stern CAJ, da Silva TR, Raymundi AM, de Souza CP, Hiroaki-Sato VA, Kato L, Guimarães FS, Andreatini R, Takahashi RN, Bertoglio LJ. Stern CAJ, et al. Among authors: takahashi rn. Neuropharmacology. 2017 Oct;125:220-230. doi: 10.1016/j.neuropharm.2017.07.024. Epub 2017 Jul 25. Neuropharmacology. 2017. PMID: 28754373
Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation.
Stern CAJ, de Carvalho CR, Bertoglio LJ, Takahashi RN. Stern CAJ, et al. Among authors: takahashi rn. Neuroscience. 2018 Feb 1;370:62-80. doi: 10.1016/j.neuroscience.2017.07.018. Epub 2017 Jul 17. Neuroscience. 2018. PMID: 28729064 Review.
Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
Stern CA, Gazarini L, Vanvossen AC, Zuardi AW, Galve-Roperh I, Guimaraes FS, Takahashi RN, Bertoglio LJ. Stern CA, et al. Eur Neuropsychopharmacol. 2015 Jun;25(6):958-65. doi: 10.1016/j.euroneuro.2015.02.001. Epub 2015 Feb 16. Eur Neuropsychopharmacol. 2015. PMID: 25799920
PTSD-like memory generated through enhanced noradrenergic activity is mitigated by a dual step pharmacological intervention targeting its reconsolidation.
Gazarini L, Stern CA, Piornedo RR, Takahashi RN, Bertoglio LJ. Gazarini L, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu026. doi: 10.1093/ijnp/pyu026. Int J Neuropsychopharmacol. 2014. PMID: 25539509 Free PMC article.
Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor.
Pamplona FA, Ferreira J, Menezes de Lima O Jr, Duarte FS, Bento AF, Forner S, Villarinho JG, Bellocchio L, Wotjak CT, Lerner R, Monory K, Lutz B, Canetti C, Matias I, Calixto JB, Marsicano G, Guimarães MZ, Takahashi RN. Pamplona FA, et al. Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):21134-9. doi: 10.1073/pnas.1202906109. Epub 2012 Nov 12. Proc Natl Acad Sci U S A. 2012. PMID: 23150578 Free PMC article.
On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment.
Stern CA, Gazarini L, Takahashi RN, Guimarães FS, Bertoglio LJ. Stern CA, et al. Neuropsychopharmacology. 2012 Aug;37(9):2132-42. doi: 10.1038/npp.2012.63. Epub 2012 May 2. Neuropsychopharmacology. 2012. PMID: 22549120 Free PMC article.
Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice.
Pamplona FA, Menezes-de-Lima O Jr, Takahashi RN. Pamplona FA, et al. Neurosci Lett. 2010 Feb 5;470(1):33-7. doi: 10.1016/j.neulet.2009.12.050. Epub 2009 Dec 28. Neurosci Lett. 2010. PMID: 20036315
Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum.
Pandolfo P, Silveirinha V, dos Santos-Rodrigues A, Venance L, Ledent C, Takahashi RN, Cunha RA, Köfalvi A. Pandolfo P, et al. Eur J Pharmacol. 2011 Mar 25;655(1-3):38-45. doi: 10.1016/j.ejphar.2011.01.013. Epub 2011 Jan 23. Eur J Pharmacol. 2011. PMID: 21266173
Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials.
Bitencourt RM, Takahashi RN. Bitencourt RM, et al. Among authors: takahashi rn. Front Neurosci. 2018 Jul 24;12:502. doi: 10.3389/fnins.2018.00502. eCollection 2018. Front Neurosci. 2018. PMID: 30087591 Free PMC article. Review.
135 results
Jump to page